Internet of Things - IOT
18 Jun 2012  |  Global
This deliverable provides insights on the many macro issues facing the pharma and biotech industry. The industry is currently in a state of transition and is faced with a myraid of challenges including the dreaded patent cliff. This research service presents a total market forecast, market share analysis by leading companies, top therapeutic class...
30 Mar 2012  |  Global
Technology Market Penetration and Roadmapping
This research service provides insights into trends and opportunities related to prebiotic technologies across a wide variety of applications in foods, feed, and personal care markets. Most of the technologies captured are from a functional and active ingredients standpoint. The research service captures the technology trends, drivers and challenge...
08 Dec 2011  |  North America
Future Opportunities and Weakness of the Radiotherapy Market
This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that ca...
Special Price $7,500.00 save 25 %
15 Apr 2011  |  Global
This research analyses the current and future economic trends and its impact on the pumps market in global biotech industry. The applications have been analysed across the globe and also a growth trend based on the three broad product classifications has been provided. The mega drivers with their corresponding implementation time have been discusse...
This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...
09 Jul 2010  |  Europe
Open Source Innovation in the context of pharma and biotech is an issue based deliverable that gives an overview of this space and analyses the key drivers and barriers of this area. It gives an overview of the key problems faced by the pharmaceutical industry today, past, present and future strategies to tackle these problems, new strategies to im...
03 Feb 2010  |  Global
This briefing from the beginning of 2010 is on macro level dynamics in the global pharmaceutical and biotechnology industry. It is being made available for the value of our subscribers.
21 Aug 2009  |  North America
This market insight on contract sales and marketing organisations throws light on the changing dynamics and the opportunities that lie ahead for these organisations in the future.
29 Jul 2009  |  Global
This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer research findings based on approximately 1,000 end-user interviews approximately 50,000 hours of...
18 May 2009  |  North America
Vital Signs - Pharmaceutical & Biotechnology Outsourcing - Growth Opportunities, Trends & Strategies
This issue of Vital Signs, released on May 18, 2009, provides a strategic overview of opportunities and issues in the pharmaceutical and biotechnology outsourcing services markets. Additionally, a company spotlight is provided for Aerie Pharmaceuticals, an emerging pharma company focused on glaucoma. Reimbursement and regulatory news from the FDA i...